Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pluristem Therapeutics Inc (NASDAQ:PSTI)

1.54
Delayed Data
As of 4:00pm ET
 0.00 / 0.00%
Today’s Change
1.04
Today|||52-Week Range
1.65
+7.69%
Year-to-Date

Today’s Trading

Previous close1.54
Today’s open1.53
Day’s range1.53 - 1.57
Volume371,349
Average volume (3 months)283,999
Market cap$150.1M
Dividend yield--
Data as of 4:00pm ET, 09/25/2017

Growth & Valuation

Earnings growth (last year)-10.34%
Earnings growth (this year)--
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book4.93

Competitors

 Today’s
change
Today’s
% change
ADVMAdverum Biotechnolog...-0.10-2.94%
EVGNEvogene Ltd+0.23+5.34%
AXSMAxsome Therapeutics ...-0.05-0.90%
KDMNKadmon Holdings Inc+0.27+7.67%
Data as of 4:02pm ET, 09/25/2017

Financials

Last reporting dateSeptember 12, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$0.00
Annual profit (last year)-$27.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Co-Chief Executive Officer
Zami Aberman
President, Co-Chief Executive Officer &
Director
Yaky Yanay
Corporate headquarters
Haifa, Haifa

Forecasts